In breast cancer, no difference is found in SOD1 levels between matched plasma and nipple aspirate fluid (NAF) from cancer patients, whereas SOD1 levels in no-cancer NAF are significantly higher compared with matched plasma (37). This evidence concerns the gene SOD1 and breast carcinoma.